Live News EQUITY FLASH L impact Nov 05, 2026, 05:31 AM UTC Telix Joins Thera4Care for Phase 1 Cancer Therapy Trial Telix is joining Thera4Care for a Phase 1 trial of a terbium-161 FAP-targeting cancer therapy. SquawkNews Desk